About PureTech Health
PureTech Health is a company based in Boston (United States) founded in 2001 by Daphne Zohar.. PureTech Health has raised $107 million across 2 funding rounds from investors including Invesco Perpetual. PureTech Health offers products and services including EndeavorRX®, LYT-100, LYT-200, and Glyph Technology Platform. PureTech Health operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, C4 Therapeutics, UCB and Grifols, among others.
- Headquarter Boston, United States
- Founders Daphne Zohar
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Puretech Health Plc
-
Annual Revenue
$4.74 M (USD)41.04as on Dec 31, 2024
-
Net Profit
$52.47 M (USD)179.24as on Dec 31, 2024
-
EBITDA
$-129.94 M (USD)8.74as on Dec 31, 2024
-
Total Equity Funding
$107 M (USD)
in 2 rounds
-
Latest Funding Round
$50 M (USD), Series D
Jan 09, 2015
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of PureTech Health
PureTech Health is a publicly listed company on the LSE with ticker symbol PRTC in UK, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of PureTech Health
PureTech Health offers a comprehensive portfolio of products and services, including EndeavorRX®, LYT-100, LYT-200, and Glyph Technology Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Digital tool for treating cognitive disorders in patients.
Investigational drug targeting specific devastating diseases.
Drug candidate for advanced disease treatment and management.
Non-opioid technology for developing new medicines.
Unlock access to complete
Unlock access to complete
Funding Insights of PureTech Health
PureTech Health has successfully raised a total of $107M across 2 strategic funding rounds. The most recent funding activity was a Series D round of $50 million completed in January 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series D — $50.0M
-
First Round
First Round
(20 Oct 2014)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2015 | Amount | Series D - PureTech Health | Valuation |
investors |
|
| Oct, 2014 | Amount | Series C - PureTech Health | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PureTech Health
PureTech Health has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Invesco Perpetual. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified investment management services are provided globally.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PureTech Health
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PureTech Health
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Puretech Health Comparisons
Competitors of PureTech Health
PureTech Health operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, C4 Therapeutics, UCB and Grifols, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Therapies for immunological and neurological disorders are developed.
|
|
| domain | founded_year | HQ Location |
Plasma-derived therapies are developed to treat multiple diseases.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Puretech Health
Frequently Asked Questions about PureTech Health
When was PureTech Health founded?
PureTech Health was founded in 2001 and raised its 1st funding round 13 years after it was founded.
Where is PureTech Health located?
PureTech Health is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Who is the current CEO of PureTech Health?
Daphne Zohar is the current CEO of PureTech Health. They have also founded this company.
Is PureTech Health a funded company?
PureTech Health is a funded company, having raised a total of $107M across 2 funding rounds to date. The company's 1st funding round was a Series C of $57M, raised on Oct 20, 2014.
What is the annual revenue of PureTech Health?
Annual revenue of PureTech Health is $4.74M as on Dec 31, 2024.
What does PureTech Health do?
PureTech Health was founded in 2001 in Boston, United States, and operates in the biotechnology sector. Immunotherapeutics are developed for multiple diseases, with lead candidates including LYT-100 for inflammation, fibrosis, and lung conditions; LYT-200, an IgG4 monoclonal antibody for pancreatic ductal adenocarcinoma, colorectal cancer, and cholangiocarcinoma; LYT-210, an IgG1 antibody for solid tumors; and LYT-300, an oral allopregnanolone formulation for neurological conditions. Early-stage funding is also provided.
Who are the top competitors of PureTech Health?
PureTech Health's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
What products or services does PureTech Health offer?
PureTech Health offers EndeavorRX®, LYT-100, LYT-200, and Glyph Technology Platform.
Is PureTech Health publicly traded?
Yes, PureTech Health is publicly traded on LSE under the ticker symbol PRTC.
Who are PureTech Health's investors?
PureTech Health has 1 investor. Key investors include Invesco Perpetual.
What is PureTech Health's ticker symbol?
The ticker symbol of PureTech Health is PRTC on LSE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.